Fig. 2From: Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transportSecondary hit validation for nuclear receptor ligands that regulate leptin transport. For outcomes from the primary screen, refer to Additional file 1: Table S4. A Compiled datasets represent the basolateral chamber leptin concentration corresponding to the noted ligand treatment, normalized to the DMSO control. Each data point is the mean of a single biological replicate calculated using three Transwell filters (n = 3 technical triplicates). Data are represented as mean ± standard deviation from n = 3 biological replicates per nuclear receptor ligand. A one-way ANOVA with a Tukey post hoc test was used to evaluate the statistical significance across conditions (*p < 0.05). B Representative TEER measurements before and after the leptin transport assay. Data are represented as mean ± standard deviation from 3 Transwell filters (n = 3 measurements per filter) per condition used in a single experiment. Trends were confirmed across two additional biological replicates, where no significant differences in TEER were noted as a function of the assayed ligandBack to article page